IP Library Granted Patent US 8,044,051
Granted Patent B2
US 8,044,051 · App. 11/626,692 · Granted Oct 25, 2011

Methods and compositions for the production of high concentration alloxazine solutions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,044,051
App. No.
11/626,692
Granted
Oct 25, 2011
Kind
B2
Abstract

Methods are provided for preparation of compositions having an enhanced level of soluble alloxazine, as compared to compositions prepared using conventional techniques. Compositions and a riboflavin form having higher solubility in solution is also provided.

Claims (6)

1. A method of increasing the concentration of an alloxazine in an aqueous medium consisting of sodium chloride to above the alloxazine's saturation point, the method comprising:

adding an amount of said alloxazine to an aqueous medium consisting of about 0.9% sodium chloride at a pH of between about 4 and about 5, wherein the amount of alloxazine exceeds the saturation point of said alloxazine at 1 atmosphere and 22° C:

heating said aqueous medium consisting of sodium chloride and alloxazine to a temperature between about 80° C. and about 90° C; and

cooling said aqueous medium consisting of sodium chloride and alloxazine to produce an aqueous medium having a concentration of alloxazine above the alloxazine saturation point.

2. The method of claim 1 , wherein the alloxazine is riboflavin.

3. The method of claim 1 , further comprising sterilizing the aqueous medium consisting of sodium chloride and alloxazine after cooling under pressure at a temperature of at least 120° C.

Assignments (2)
CHANGE OF NAME Recorded Feb 16, 2012
From: CARIDIANBCT BIOTECHNOLOGIES, LLC.
To: TERUMO BCT BIOTECHNOLOGIES, LLC
Reel/Frame 027715/0552 →
RELEASE OF SECURITY INTEREST Recorded Aug 11, 2011
From: CITICORP TRUSTEE COMPANY LIMITED, AS SECUIRTY AGENT
To: CARIDIANBCT BIOTECHNOLOGIES, LLC
Reel/Frame 026737/0537 →